Company intelligence / Profile preview

CXO Fund

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

CXO Fund is a specialized venture capital firm that invests in early-stage life science and healthcare companies. The fund is distinguished by its leadership team, which consists of experienced C-suite executives (CXOs) from the biotechnology and pharmaceutical industries. Beyond providing capital, the fund leverages the deep operational, strategic, and technical expertise of its partners to support the growth and development of its portfolio companies. CXO Fund typically targets innovative startups in therapeutics, diagnostics, and medical technology. By bridging the gap between financial investment and operational leadership, the fund aims to accelerate the translation of scientific discoveries into commercial successes.

Industry: Investors

Beyond the preview

Go deeper on CXO Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CXO Fund.

Explore the full profile